Cyclophosphamide-d4 |
| カタログ番号GC47148 |
シクロホスファミド-d4 は、重水素標識シクロホスファミドです。シクロホスファミドは、抗腫瘍活性、免疫抑制剤である窒素マスタードに化学的に関連する合成アルキル化剤です。
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 173547-45-0
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Cyclophosphamide-d4 contains four deuterium atoms. It is intended for use as an internal standard for the quantification of cyclophosphamide by GC- or LC-MS. Cyclophosphamide is a nitrogen mustard alkylating agent used in the treatment of cancers and autoimmune disorders.1,2 In cells with low levels of aldehyde dehydrogenase, cyclophosphamide acts as a prodrug and is metabolized to the active compound phosphoramide mustard, which crosslinks with DNA and causes cell death.3,4
1.Yildirim-Toruner, C., and Diamond, B.Current and novel therapeutics in the treatment of systemic lupus erythematosusJ. Allergy Clin. Immunol.127(2)303-314(2011) 2.Appel, G.B.New and future therapies for lupus nephritisCleve. Clin. J. Med.79(2)134-140(2012) 3.Ahmed, A.R., and Hombal, S.M.Cyclophosphamide (Cytoxan). A review on relevant pharmacology and clinical usesJ. Am. Acad. Dermatol.11(6)1115-1126(1984) 4.Bischoff, P.L., Holl, V., Coelho, D., et al.Apoptosis at the interface of immunosuppressive and anticancer activities: The examples of two classes of chemical inducers, oxysterols and alkylating agentsCurr. Med. Chem.7(7)693-713(2000)
Average Rating: 5 (Based on Reviews and 4 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *